Potential effects of nicotine on glioblastoma and chemoradiotherapy: a review

References

• Stupp R, Taillibert S, Kanner A, et al. Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. JAMA. 2017;318:2306–2316.
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason WP, van Den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–996.
   PubMed Web of Science ®Google Scholar
• Silvera SAN, Miller AB, Rohan TE. Cigarette smoking and risk of glioma: a prospective cohort study. Int J Cancer. 2006;118:1848–1851.
   PubMed Web of Science ®Google Scholar
• Efird JT, Friedman GD, Sidney S, et al. The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors. J Neurooncol. 2004;68:57–69.
   PubMed Web of Science ®Google Scholar
• Holick CN, Giovannucci EL, Rosner B, et al. Prospective study of cigarette smoking and adult glioma: dosage, duration, and latency. Neuro-Oncol. 2007;9:326–334.
   PubMed Web of Science ®Google Scholar
• Lachance DH, Yang P, Johnson DR, et al. Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking. Am J Epidemiol. 2011;174:574–581.
   PubMed Web of Science ®Google Scholar
• Vida S, Richardson L, Cardis E, et al. Brain tumours and cigarette smoking: analysis of the INTERPHONE Canada case-control study. Environ Health Glob Access Sci Source. 2014;13:55.
   PubMed Web of Science ®Google Scholar
• Li H-X, Peng -X-X, Zong Q, et al. Cigarette smoking and risk of adult glioma: a meta-analysis of 24 observational studies involving more than 2.3 million individuals. OncoTargets Ther. 2016;9:3511–3523.
   PubMed Web of Science ®Google Scholar
• Hochberg F, Toniolo P, Cole P, et al. Nonoccupational risk indicators of glioblastoma in adults. J Neurooncol. 1990;8:55–60.
   PubMed Web of Science ®Google Scholar
• Hou L, Jiang J, Liu B, et al. Smoking and adult glioma: a population-based case-control study in China. Neuro-Oncol. 2016;18:105–113.
   PubMed Web of Science ®Google Scholar
• Gritz ER, Dresler C, Sarna L. Smoking, the missing drug interaction in clinical trials: ignoring the obvious. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2005;14:2287–2293.
   Google Scholar
• Gregorio DI, Hollenbeck M, Samociuk H. Who’s assessing tobacco use in cancer clinical trials? Nicotine Tob Res Off J Soc Res Nicotine Tob. 2009;11:1354–1358.
   PubMed Web of Science ®Google Scholar
• Cataldo JK, Dubey S, Prochaska JJ. Smoking cessation: an integral part of lung cancer treatment. Oncology. 2010;78:289–301.
   PubMed Web of Science ®Google Scholar
• Florou AN, Gkiozos ICH, Tsagouli SK, et al. Clinical significance of smoking cessation in subjects with cancer: a 30-year review. Respir Care. 2014;59:1924–1936.
   PubMed Web of Science ®Google Scholar
• Mishra A, Chaturvedi P, Datta S, et al. Harmful effects of nicotine. Indian J Med Paediatr Oncol Off J Indian Soc Med Paediatr Oncol. 2015;36:24–31.
   PubMed Web of Science ®Google Scholar
• Sanner T, Grimsrud TK. Nicotine: carcinogenicity and effects on response to cancer treatment–a review. Front Oncol. 2015;5:196.
   PubMed Web of Science ®Google Scholar
• Shenker RF, McTyre ER, Ruiz J, et al. The effects of smoking status and smoking history on patients with brain metastases from lung cancer. Cancer Med. 2017;6:944–952.
   PubMed Web of Science ®Google Scholar
• Burke L, Miller L-A, Saad A, et al. Smoking behaviors among cancer survivors: an observational clinical study. J Oncol Pract. 2009;5:6–9.
   PubMedGoogle Scholar
• Tseng T-S, Lin H-Y, Moody-Thomas S, et al. Who tended to continue smoking after cancer diagnosis: the national health and nutrition examination survey 1999–2008. BMC Public Health. 2012;12:784.
   PubMed Web of Science ®Google Scholar
• Mutlu H, Akca Z, Erden A, et al. Lack of sunlight exposure influence on primary glioblastoma survival. Asian Pac J Cancer Prev APJCP. 2014;15:4165–4168.
   PubMedGoogle Scholar
• Seliger C, Ricci C, Meier CR, et al. Diabetes, use of antidiabetic drugs, and the risk of glioma. Neuro-Oncol. 2016;18:340–349.
   PubMed Web of Science ®Google Scholar
• Lim G, Ho C, Roldan Urgoti G, et al. Risk of venous thromboembolism in glioblastoma patients. Cureus. 2018;10:e2678.
   PubMed Web of Science ®Google Scholar
• Berger MR, Zeller WJ. Interaction of nicotine with anticancer treatment. Klin Wochenschr. 1988;66(Suppl 11):127–133.
   PubMedGoogle Scholar
• Petros WP, Younis IR, Ford JN, et al. Effects of tobacco smoking and nicotine on cancer treatment. Pharmacotherapy. 2012;32:920–931.
   PubMed Web of Science ®Google Scholar
• Dasgupta P, Rizwani W, Pillai S, et al. Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines. Int J Cancer. 2009;124:36–45.
   PubMed Web of Science ®Google Scholar
• Dinicola S, Morini V, Coluccia P, et al. Nicotine increases survival in human colon cancer cells treated with chemotherapeutic drugs. Toxicol Vitro Int J Publ Assoc BIBRA. 2013;27:2256–2263.
   PubMed Web of Science ®Google Scholar
• Kyte SL, Gewirtz DA. The influence of nicotine on lung tumor growth, cancer chemotherapy, and chemotherapy-induced peripheral neuropathy. J Pharmacol Exp Ther. 2018;366:303–313.
   PubMed Web of Science ®Google Scholar
• Khalil AA, Jameson MJ, Broaddus WC, et al. Nicotine enhances proliferation, migration, and radioresistance of human malignant glioma cells through EGFR activation. Brain Tumor Pathol. 2013;30:73–83.
   PubMed Web of Science ®Google Scholar
• Scripture CD, Figg WD. Drug interactions in cancer therapy. Nat Rev Cancer. 2006;6:546–558.
   PubMed Web of Science ®Google Scholar
• Warren GW, Romano MA, Kudrimoti MR, et al. Nicotinic modulation of therapeutic response in vitro and in vivo. Int J Cancer. 2012;131:2519–2527.
   PubMed Web of Science ®Google Scholar
• Czyżykowski R, Połowinczak-Przybyłek J, Potemski P. Nicotine-induced resistance of non-small cell lung cancer to treatment–possible mechanisms. Postepy Hig Med Doswiadczalnej Online. 2016;70:186–193.
   PubMed Web of Science ®Google Scholar
• Anderson FA, Glioma Outcomes Project Advisory Board. The glioma outcomes project: a resource for measuring and improving glioma outcomes. Neurosurg Focus. 1998;4:e8.
   PubMedGoogle Scholar
• Chang SM, Parney IF, Huang W, et al. Patterns of care for adults with newly diagnosed malignant glioma. JAMA. 2005;293:557–564.
   PubMed Web of Science ®Google Scholar
• Tang-Aroonsin S. Glioma of the central nervous system: factors affecting the outcome. J Med Assoc Thail Chotmaihet Thangphaet. 2001;84:417–421.
   PubMedGoogle Scholar
• Paravati AJ, Heron DE, Landsittel D, et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of radiation therapy oncology group-recursive partitioning analysis in the IMRT and temozolomide era. J Neurooncol. 2011;104:339–349.
   PubMed Web of Science ®Google Scholar
• Zhang J, Kamdar O, Le W, et al. Nicotine induces resistance to chemotherapy by modulating mitochondrial signaling in lung cancer. Am J Respir Cell Mol Biol. 2009;40:135–146.
   PubMed Web of Science ®Google Scholar
• Grando SA. Connections of nicotine to cancer. Nat Rev Cancer. 2014;14:419.
   PubMed Web of Science ®Google Scholar
• Yuge K, Kikuchi E, Hagiwara M, et al. Nicotine induces tumor growth and chemoresistance through activation of the PI3K/Akt/mTOR pathway in bladder cancer. Mol Cancer Ther. 2015;14:2112.
   PubMed Web of Science ®Google Scholar
• Chernyavsky AI, Shchepotin IB, Galitovkiy V, et al. Mechanisms of tumor-promoting activities of nicotine in lung cancer: synergistic effects of cell membrane and mitochondrial nicotinic acetylcholine receptors. BMC Cancer [Internet]. 2015 [cited 2019 Mar 21];15. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369089/
   PubMed Web of Science ®Google Scholar
• PubMed – NCBI [Internet]. Mechanisms for nicotine in the development and progression of gastrointestinal cancers. [cited 2019 Mar 21]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/22701817
   Google Scholar
• Warren GW, Rangnekar V, McGarry R, et al. Pathways of resistance: potential effects of nicotine on cancer and treatment response. Int J Radiat Oncol Biol Phys. 2008;72:S715.
   Web of Science ®Google Scholar
• Yamamura M, Amano Y, Sakagami H, et al. Calcium mobilization during nicotine-induced cell death in human glioma and glioblastoma cell lines. Anticancer Res. 1998;18:2499–2502.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Gaztelumendi A, Alvehus M, Andersson T, et al. Comparison of the effects of nicotine upon the transcellular electrical resistance and sucrose permeability of human ECV304/rat C6 co-cultures and human CaCo₂ cells. Toxicol Lett. 2011;207:1–6.
   PubMed Web of Science ®Google Scholar
• Barik J, Wonnacott S. Molecular and cellular mechanisms of action of nicotine in the CNS. In: Henningfield JE, London ED, Pogun S, editors. Nicotine psychopharmacol [ Internet]. Berlin, Heidelberg: Springer Berlin Heidelberg; 2009. p. 173–207.
   Google Scholar
• Pennell NA, Lynch TJ. Combined inhibition of the VEGFR and EGFR signaling pathways in the treatment of NSCLC. The Oncologist. 2009;14:399–411.
   PubMed Web of Science ®Google Scholar
• Nava-Salazar S, Gómez-Manzo S, Marcial-Quino J, et al. Effect of nicotine on CYP2B1 expression in a glioma animal model and analysis of CYP2B6 expression in pediatric gliomas. Int J Mol Sci 2018; 19:1790.
   Google Scholar
• Singh S, Pillai S, Chellappan S. Nicotinic acetylcholine receptor signaling in tumor growth and metastasis. J Oncol. 2011;2011:456743.
   PubMedGoogle Scholar
• Nakada M, Okada Y, Yamashita J. The role of matrix metalloproteinases in glioma invasion. Front Biosci J Virtual Libr. 2003;8:e261–269.
   PubMed Web of Science ®Google Scholar
• Dom AM, Buckley AW, Brown KC, et al. The α7-nicotinic acetylcholine receptor and MMP-2/-9 pathway mediate the proangiogenic effect of nicotine in human retinal endothelial cells. Invest Ophthalmol Vis Sci. 2011;52:4428–4438.
   PubMed Web of Science ®Google Scholar
• Xue Q, Cao L, Chen X-Y, et al. High expression of MMP9 in glioma affects cell proliferation and is associated with patient survival rates. Oncol Lett. 2017;13:1325–1330.
   PubMed Web of Science ®Google Scholar
• Yu W-F, Guan -Z-Z, Bogdanovic N, et al. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer’s disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques. Exp Neurol. 2005;192:215–225.
   PubMed Web of Science ®Google Scholar
• Yang T, Xiao T, Sun Q, et al. The current agonists and positive allosteric modulators of α7 nAChR for CNS indications in clinical trials. Acta Pharm Sin B. 2017;7:611–622.
   PubMed Web of Science ®Google Scholar
• Toll L, Jimenez L, Waleh N, et al. {Beta}2-adrenergic receptor agonists inhibit the proliferation of 1321N1 astrocytoma cells. J Pharmacol Exp Ther. 2011;336:524–532.
   PubMed Web of Science ®Google Scholar
• He -J-J, Zhang W-H, Liu S-L, et al. Activation of β-adrenergic receptor promotes cellular proliferation in human glioblastoma. Oncol Lett. 2017;14:3846–3852.
   PubMed Web of Science ®Google Scholar
• Schaal C, Chellappan SP. Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers. Mol Cancer Res MCR. 2014;12:14–23.
   PubMed Web of Science ®Google Scholar
• Wang W, Liu F, Wang C, et al. Glutathione S-transferase A1 mediates nicotine-induced lung cancer cell metastasis by promoting epithelial-mesenchymal transition. Exp Ther Med. 2017;14:1783–1788.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zeng A, Liu S, et al. Genome-wide identification of epithelial-mesenchymal transition-associated microRNAs reveals novel targets for glioblastoma therapy. Oncol Lett. 2018;15:7625–7630.
   PubMed Web of Science ®Google Scholar
• Hirata N, Sekino Y, Kanda Y. Nicotine increases cancer stem cell population in MCF-7 cells. Biochem Biophys Res Commun. 2010;403:138–143.
   PubMed Web of Science ®Google Scholar
• Schaal CM, Bora-Singhal N, Kumar DM, et al. Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer. Mol Cancer. 2018;17:149.
   PubMed Web of Science ®Google Scholar
• Türker Şener L, Güven C, Şener A, et al. Nicotine reduces effectiveness of doxorubicin chemotherapy and promotes CD44+CD24- cancer stem cells in MCF-7 cell populations. Exp Ther Med. 2018;16:21–28.
   PubMed Web of Science ®Google Scholar
• Sakariassen PØ, Immervoll H, Chekenya M. Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies. Neoplasia N Y N. 2007;9:882–892.
   PubMed Web of Science ®Google Scholar
• Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444:756–760.
   PubMed Web of Science ®Google Scholar
• Chen J, Li Y, Yu T-S, et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature. 2012;488:522–526.
   PubMed Web of Science ®Google Scholar
• Lathia JD, Mack SC, Mulkearns-Hubert EE, et al. Cancer stem cells in glioblastoma. Genes Dev. 2015;29:1203–1217.
   PubMed Web of Science ®Google Scholar
• Kohutek ZA, diPierro CG, Redpath GT, et al. ADAM-10-mediated N-cadherin cleavage is protein Kinase C-α–dependent and promotes glioblastoma cell migration. J Neurosci Off J Soc Neurosci. 2009;29:4605–4615.
   PubMed Web of Science ®Google Scholar
• Phillips E, Lang V, Bohlen J, et al. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism. Int J Cancer. 2016;139:1776–1787.
   PubMed Web of Science ®Google Scholar
• Guha P, Bandyopadhyaya G, Polumuri SK, et al. Nicotine promotes apoptosis resistance of breast cancer cells and enrichment of side population cells with cancer stem cell-like properties via a signaling cascade involving galectin-3, α9 nicotinic acetylcholine receptor and STAT3. Breast Cancer Res Treat. 2014;145:5–22.
   PubMed Web of Science ®Google Scholar
• Stechishin OD, Luchman HA, Ruan Y, et al. On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells. Neuro-Oncol. 2013;15:198–207.
   PubMed Web of Science ®Google Scholar
• Brahimi-Horn MC, Pouysségur J. HIF at a glance. J Cell Sci. 2009;122:1055–1057.
   PubMed Web of Science ®Google Scholar
• Lee J, Cooke JP. Nicotine and pathological angiogenesis. Life Sci. 2012;91:1058–1064.
   PubMed Web of Science ®Google Scholar
• Guo L, Li L, Wang W, et al. Mitochondrial reactive oxygen species mediates nicotine-induced hypoxia-inducible factor-1α expression in human non-small cell lung cancer cells. Biochim Biophys Acta. 2012;1822:852–861.
   PubMed Web of Science ®Google Scholar
• Monteiro AR, Hill R, Pilkington GJ, et al. The role of hypoxia in glioblastoma invasion. Cells. 2017; 6:45.
   Google Scholar
• Minchenko OH, Tsymbal DO, Minchenko DO, et al. Hypoxic regulation of the expression of cell proliferation related genes in U87 glioma cells upon inhibition of IRE1 signaling enzyme. Ukr Biochem J. 2016;88:11–21.
   PubMedGoogle Scholar
• Kaur B, Khwaja FW, Severson EA, et al. Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro-Oncol. 2005;7:134–153.
   PubMed Web of Science ®Google Scholar
• Gabriely G, Wheeler MA, Takenaka MC, et al. Role of AHR and HIF-1α in glioblastoma metabolism. Trends Endocrinol Metab TEM. 2017;28:428–436.
   PubMed Web of Science ®Google Scholar
• Ogu CC, Maxa JL. Drug interactions due to cytochrome P450. Proc Bayl Univ Med Cent. 2000;13:421–423.
   PubMedGoogle Scholar
• Howard LA, Miksys S, Hoffmann E, et al. Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics. Br J Pharmacol. 2003;138:1376–1386.
   PubMed Web of Science ®Google Scholar
• Pal D, Kwatra D, Minocha M, et al. Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals. Life Sci. 2011;88:959–971.
   PubMed Web of Science ®Google Scholar
• Baker SD, Wirth M, Statkevich P, et al. Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer. Clin Cancer Res. 1999;5:309–317.
   PubMed Web of Science ®Google Scholar
• Jen JF, Cutler DL, Pai SM, et al. Population pharmacokinetics of temozolomide in cancer patients. Pharm Res. 2000;17:1284–1289.
   PubMed Web of Science ®Google Scholar
• Li H, Shi Q. Drugs and diseases interacting with cigarette smoking in US prescription drug labelling. Clin Pharmacokinet. 2015;54:493–501.
   PubMed Web of Science ®Google Scholar
• Drugs–DrugBank [Internet]. [cited 2018 Dec 11]. Available from: https://www.drugbank.ca/drugs
   Google Scholar
• Carmustine [Internet]. [cited 2018 Dec 11]. Available from: https://livertox.nih.gov/Carmustine.htm
   Google Scholar
• Breedveld P, Zelcer N, Pluim D, et al. Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions. Cancer Res. 2004;64:5804–5811.
   PubMed Web of Science ®Google Scholar
• Lee SY. Temozolomide resistance in glioblastoma multiforme. Genes Dis. 2016;3:198–210.
   PubMed Web of Science ®Google Scholar
• Haas B, Klinger V, Keksel C, et al. Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs. Cancer Cell Int. 2018;18:69.
   PubMed Web of Science ®Google Scholar
• Pearson JRD, Regad T. Targeting cellular pathways in glioblastoma multiforme. Signal Transduct Target Ther. 2017;2:17040.
   PubMed Web of Science ®Google Scholar
• Li Y, Papke RL, He YJ, et al. Characterization of the neuroprotective and toxic effects of alpha7 nicotinic receptor activation in PC12 cells. Brain Res. 1999;830:218–225.
   PubMed Web of Science ®Google Scholar
• Guan -Z-Z, Yu W-F, Nordberg A. Dual effects of nicotine on oxidative stress and neuroprotection in PC12 cells. Neurochem Int. 2003;43:243–249.
   PubMed Web of Science ®Google Scholar
• Chen C-S, Lee -S-S, Yu H-C, et al. Effects of nicotine on cell growth, migration, and production of inflammatory cytokines and reactive oxygen species by cementoblasts. J Dent Sci. 2015;10:154–160.
   Web of Science ®Google Scholar
• Salazar-Ramiro A, Ramírez-Ortega D, Pérez de la Cruz V, et al. Role of redox status in development of glioblastoma. Front Immunol. 2016;7:156.
   PubMed Web of Science ®Google Scholar
• Liou G-Y, Storz P. Reactive oxygen species in cancer. Free Radic Res. 2010;44:479–496.
   PubMed Web of Science ®Google Scholar
• Shi J, Sun B, Shi W, et al. Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation. Tumor Biol. 2015;36:655–662.
   PubMed Web of Science ®Google Scholar
• Dong F, Eibach M, Bartsch JW, et al. The metalloprotease-disintegrin ADAM8 contributes to temozolomide chemoresistance and enhanced invasiveness of human glioblastoma cells. Neuro-Oncol. 2015;17:1474–1485.
   PubMed Web of Science ®Google Scholar
• Li Q, Chen B, Cai J, et al. Comparative analysis of matrix metalloproteinase family members reveals that MMP9 predicts survival and response to temozolomide in patients with primary glioblastoma. PLoS One. 2016;11:e0151815.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Fujioka K, Ikeda K, et al. Temozolomide does not influence the transcription or activity of matrix metalloproteinases 9 and 2 in glioma cell lines. J Clin Neurosci Off J Neurosurg Soc Australas. 2017;41:144–149.
   PubMed Web of Science ®Google Scholar
• Armand J-P, Ribrag V, Harrousseau J-L, et al. Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors. Ther Clin Risk Manag. 2007;3:213–224.
   PubMedGoogle Scholar
• Kambayashi S, Minami K, Ogawa Y, et al. Expression of O(6)-methylguanine-DNA methyltransferase causes lomustine resistance in canine lymphoma cells. Can J Vet Res Rev Can Rech Veterinaire. 2015;79:201–209.
   PubMed Web of Science ®Google Scholar
• Christmann M, Kaina B. (O6)-methylguanine-DNA methyltransferase (MGMT): impact on cancer risk in response to tobacco smoke. Mutat Res. 2012;736:64–74.
   PubMed Web of Science ®Google Scholar
• Nagane M, Asai A, Shibui S, et al. Expression pattern of chemoresistance-related genes in human malignant brain tumors: a working knowledge for proper selection of anticancer drugs. Jpn J Clin Oncol. 1999;29:527–534.
   PubMed Web of Science ®Google Scholar
• Borst P, Evers R, Kool M, et al. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst. 2000;92:1295–1302.
   PubMed Web of Science ®Google Scholar
• Régina A, Demeule M, Laplante A, et al. Multidrug resistance in brain tumors: roles of the blood-brain barrier. Cancer Metastasis Rev. 2001;20:13–25.
   PubMed Web of Science ®Google Scholar
• Genovese I, Ilari A, Assaraf YG, et al. Not only P-glycoprotein: amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins. Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother. 2017;32:23–46.
   Google Scholar
• Zeng H, Chen ZS, Belinsky MG, et al. Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport. Cancer Res. 2001;61:7225–7232.
   PubMed Web of Science ®Google Scholar
• Tsuruo T, Iida H, Tsukagoshi S, et al. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 1981;41:1967–1972.
   PubMed Web of Science ®Google Scholar
• Joy A, Panicker S, Shapiro JR. Altered nuclear localization of bax protein in BCNU-resistant glioma cells. J Neurooncol. 2000;49:117–129.
   PubMed Web of Science ®Google Scholar
• Del Bufalo D, Trisciuoglio D, Biroccio A, et al. Bcl-2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity. J Cell Biochem. 2001;83:473–483.
   PubMed Web of Science ®Google Scholar
• Nishioka T, Luo L-Y, Shen L, et al. Nicotine increases the resistance of lung cancer cells to cisplatin through enhancing Bcl-2 stability. Br J Cancer. 2014;110:1785–1792.
   PubMed Web of Science ®Google Scholar
• Bacolod MD, Johnson SP, Ali-Osman F, et al. Mechanisms of resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea in human medulloblastoma and rhabdomyosarcoma. Mol Cancer Ther. 2002;1:727–736.
   PubMed Web of Science ®Google Scholar
• Ali-Osman F, Stein DE, Renwick A. Glutathione content and glutathione-S-transferase expression in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human malignant astrocytoma cell lines. Cancer Res. 1990;50:6976–6980.
   PubMed Web of Science ®Google Scholar
• Chen HHW, Kuo MT. Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy. Met Based Drugs. 2010;2010.
   PubMedGoogle Scholar
• Moscow JA. Methotrexate transport and resistance. Leuk Lymphoma. 1998;30:215–224.
   PubMed Web of Science ®Google Scholar
• Jansen G, Pieters R. The role of impaired transport in (pre)clinical resistance to methotrexate: insights on new antifolates. Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother. 1998;1:211–218.
   Google Scholar
• Housman G, Byler S, Heerboth S, et al. Drug resistance in cancer: an overview. Cancers. 2014;6:1769–1792.
   PubMed Web of Science ®Google Scholar
• Banerjee D, Mayer-Kuckuk P, Capiaux G, et al. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochim Biophys Acta. 2002;1587:164–173.
   PubMed Web of Science ®Google Scholar
• Sarkaria JN, Kitange GJ, James CD, et al. Mechanisms of chemoresistance in malignant glioma. Clin Cancer Res Off J Am Assoc Cancer Res. 2008;14:2900–2908.
   PubMed Web of Science ®Google Scholar
• Kool M, van der Linden M, de Haas M, et al. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci U S A. 1999;96:6914–6919.
   PubMed Web of Science ®Google Scholar
• Donnenberg VS, Meyer EM, Donnenberg AD. Measurement of multiple drug resistance transporter activity in putative cancer stem/progenitor cells. Methods Mol Biol Clifton NJ. 2009;568:261–279.
   PubMedGoogle Scholar
• Moitra K. Overcoming multidrug resistance in cancer stem cells. BioMed Res Int. 2015;2015:635745.
   PubMed Web of Science ®Google Scholar
• Manda VK, Mittapalli RK, Bohn KA, et al. Nicotine and cotinine increases the brain penetration of saquinavir in rat. J Neurochem. 2010;115:1495–1507.
   PubMed Web of Science ®Google Scholar
• Thottassery JV, Zambetti GP, Arimori K, et al. p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents. Proc Natl Acad Sci U S A. 1997;94:11037–11042.
   PubMed Web of Science ®Google Scholar
• Dasgupta P, Kinkade R, Joshi B, et al. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci U S A. 2006;103:6332–6337.
   PubMed Web of Science ®Google Scholar
• Chen L, Wang H. Nicotine promotes human papillomavirus (HPV)-immortalized cervical epithelial cells (H8) proliferation by activating RPS27a-Mdm2-P53 pathway in vitro. Toxicol Sci. 2019;167:408-418.
   Google Scholar
• Létourneau IJ, Bowers RJ, Deeley RG, et al. Limited modulation of the transport activity of the human multidrug resistance proteins MRP1, MRP2 and MRP3 by nicotine glucuronide metabolites. Toxicol Lett. 2005;157:9–19.
   PubMed Web of Science ®Google Scholar
• Guo J, Chu M, Abbeyquaye T, et al. Persistent nicotine treatment potentiates amplification of the dihydrofolate reductase gene in rat lung epithelial cells as a consequence of Ras activation. J Biol Chem. 2005;280:30422–30431.
   PubMed Web of Science ®Google Scholar
• Baskar R, Dai J, Wenlong N, et al. Biological response of cancer cells to radiation treatment. Front Mol Biosci. 2014;1:24.
   PubMed Web of Science ®Google Scholar
• Nyati MK, Morgan MA, Feng FY, et al. Integration of EGFR inhibitors with radiochemotherapy. Nat Rev Cancer. 2006;6:876–885.
   PubMed Web of Science ®Google Scholar
• Rodemann HP, Dittmann K, Toulany M. Radiation-induced EGFR-signaling and control of DNA-damage repair. Int J Radiat Biol. 2007;83:781–791.
   PubMed Web of Science ®Google Scholar
• Rodemann HP, Blaese MA. Responses of normal cells to ionizing radiation. Semin Radiat Oncol. 2007;17:81–88.
   PubMed Web of Science ®Google Scholar